Associate Professor
Harvard Medical School
Boston, Massachusetts
Dr. Peter R Chai is an associate professor of emergency medicine and medical toxicology at Brigham and Women’s Hospital/Harvard Medical School, and affiliate research scholar at the Koch Institute for Integrated Cancer Research at the Massachusetts Institute of Technology, and The Fenway Institute. He is also research faculty at the Dana Farber Cancer Institute. Dr. Chai’s research portfolio includes the use of ingestible electronic sensors and other technologies for medication adherence, development of drug delivery mechanisms along the continuum of animal to first in man translation and investigations in drug toxicity and treatment. He has developed ingestible sensors, microparticle taggants, smartphone digital phenotyping and other strategies that measure and define the context in which adherence and nonadherence occur. These platforms serve as a basis for behavioral interventions that reinforce adherence. Dr. Chai’s work includes translational research in involve injectable, implantable and gastrointestinal interface devices to facilitate drug delivery. Finally, Dr. Chai’s lab also investigates novel treatments and surveillance strategies to address substance use disorders in the ED, community and outpatient setting. This body of work also include formative work surrounding the application of cannabis and cannabinoids to address symptom burden in individuals living with cancer.
Virtual
Disclosure information not submitted.
